Literature DB >> 28594725

Pelvic Exenteration Surgery: The Evolution of Radical Surgical Techniques for Advanced and Recurrent Pelvic Malignancy.

Kilian G M Brown1, Michael J Solomon, Cherry E Koh.   

Abstract

Pelvic exenteration was first described by Alexander Brunschwig in 1948 in New York as a palliative procedure for recurrent carcinoma of the cervix. Because of initially high rates of morbidity and mortality, the practice of this ultraradical operation was largely confined to a small number of American centers for most of the 20 century. The post-World War II era saw advances in anaesthesia, blood transfusion, and intensive care medicine that would facilitate the evolution of more radical and heroic abdominal and pelvic surgery. In the last 3 decades, pelvic exenteration has continued to evolve into one of the most important treatments for locally advanced and recurrent rectal cancer. This review aimed to explore the evolution of pelvic exenteration surgery and to identify the pioneering surgeons, seminal articles, and novel techniques that have led to its current status as the procedure of choice for locally advanced and recurrent rectal cancer.

Entities:  

Mesh:

Year:  2017        PMID: 28594725     DOI: 10.1097/DCR.0000000000000839

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  12 in total

1.  PRehabIlitatiOn with pReoperatIve exercise and educaTion for patients undergoing major abdominal cancer surgerY: protocol for a multicentre randomised controlled TRIAL (PRIORITY TRIAL).

Authors:  Daniel Steffens; Jane Young; Bernhard Riedel; Rachael Morton; Linda Denehy; Alexander Heriot; Cherry Koh; Qiang Li; Adrian Bauman; Charbel Sandroussi; Hilmy Ismail; Mbathio Dieng; Nabila Ansari; Neil Pillinger; Sarah O'Shannassy; Sam McKeown; Derek Cunningham; Kym Sheehan; Gino Iori; Jenna Bartyn; Michael Solomon
Journal:  BMC Cancer       Date:  2022-04-22       Impact factor: 4.638

2.  Minimally invasive surgery techniques in pelvic exenteration: a systematic and meta-analysis review.

Authors: 
Journal:  Surg Endosc       Date:  2018-07-17       Impact factor: 4.584

Review 3.  Pelvic exenteration for locally advanced and recurrent rectal cancer-how much more?

Authors:  Yee Chen Lau; Kilian G M Brown; Peter Lee
Journal:  J Gastrointest Oncol       Date:  2019-12

4.  Exploring reasons behind patient compliance with nutrition supplements before pelvic exenteration surgery.

Authors:  Sophie E Hogan; Michael J Solomon; Sharon K Carey
Journal:  Support Care Cancer       Date:  2018-09-05       Impact factor: 3.603

Review 5.  The role of imaging in pelvic exenteration for gynecological cancers.

Authors:  Pamela Ines Causa Andrieu; Sungmin Woo; Eric Rios-Doria; Yukio Sonoda; Soleen Ghafoor
Journal:  Br J Radiol       Date:  2021-05-07       Impact factor: 3.629

6.  Cohort study of long-term survival and quality of life following pelvic exenteration.

Authors:  D Steffens; M J Solomon; J M Young; C Koh; R L Venchiarutti; P Lee; K Austin
Journal:  BJS Open       Date:  2018-05-22

7.  Feasibility and acceptability of a preoperative exercise program for patients undergoing major cancer surgery: results from a pilot randomized controlled trial.

Authors:  Daniel Steffens; Jane Young; Paula R Beckenkamp; James Ratcliffe; Freya Rubie; Nabila Ansari; Neil Pillinger; Cherry Koh; Phillip A Munoz; Michael Solomon
Journal:  Pilot Feasibility Stud       Date:  2021-01-13

Review 8.  Contemporary Management of Locally Advanced and Recurrent Rectal Cancer: Views from the PelvEx Collaborative.

Authors: 
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.575

Review 9.  Urinary diversion after pelvic exenteration for gynecologic malignancies.

Authors:  Carlos Martínez-Gómez; Martina Aida Angeles; Alejandra Martinez; Bernard Malavaud; Gwenael Ferron
Journal:  Int J Gynecol Cancer       Date:  2020-11-23       Impact factor: 3.437

Review 10.  Surgical treatment of locally recurrent rectal cancer: a narrative review.

Authors:  Zhaoya Gao; Jin Gu
Journal:  Ann Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.